Enantiospecificity of glutamate carboxypeptidase II inhibition.

@article{Tsukamoto2005EnantiospecificityOG,
  title={Enantiospecificity of glutamate carboxypeptidase II inhibition.},
  author={T. Tsukamoto and P. Majer and D. Vitharana and C. Ni and Bunda Hin and X. Lu and Ajit G. Thomas and K. Wozniak and D. Calvin and Y. Wu and B. Slusher and D. Scarpetti and G. Bonneville},
  journal={Journal of medicinal chemistry},
  year={2005},
  volume={48 7},
  pages={
          2319-24
        }
}
Two representative glutamate carboxypeptidase II (GCP II) inhibitors, 2-(hydroxypentafluorophenylmethyl-phosphinoylmethyl)pentanedioic acid 2 and 2-(3-mercaptopropyl)pentanedioic acid 3, were synthesized in high optical purities (>97%ee). The two enantiomers of 2 were prepared from previously reported chiral intermediates, (R)- and (S)-2-(hydroxyphosphinoylmethyl)pentanedioic acid benzyl esters 8. The synthesis of (R)- and (S)-3 involves the hydrolysis of (R)- and (S)-3-(2-oxo-tetrahydro… Expand
δ-Thiolactones as prodrugs of thiol-based glutamate carboxypeptidase II (GCPII) inhibitors.
TLDR
Thiolactones derived from thiol-based glutamate carboxypeptidase II inhibitors exhibited efficacy in a rat model of neuropathic pain following oral administration, consistent with the oral plasma pharmacokinetics. Expand
Human glutamate carboxypeptidase II inhibition: structures of GCPII in complex with two potent inhibitors, quisqualate and 2-PMPA.
TLDR
Crystal structures were determined of the extracellular part of GCPII in complex with two potent inhibitors, quisqualate and 2-PMPA, and models were constructed for binding of the inhibitors willardiine, homoibotenate, L-2-amino-4-phosphonobutanoic acid and L-serine-O-sulfate to the S1' site of the enzyme. Expand
Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs.
TLDR
The S1 pocket of GCPII could be accurately defined and analyzed for the first time, and the data indicate the importance of Asn519, Arg463, Arg534, and Arg536 for recognition of the penultimate substrate residues, as well as mechanistic explanation of G CPII preference for acidic dipeptides. Expand
Design, synthesis and pharmacological activity of novel enantiomerically pure phosphonic acid-based NAALADase inhibitors.
TLDR
A series of novel enantiomerically pure 2-(phosphonomethyl)pentanedioic acid (2- PMPA) based NAALADase inhibitors were synthesized and showed activity similar to the known potent inhibitor (S)-2-PMPA. Expand
Design, synthesis, and metal binding of novel Pseudo- oligopeptides containing two phosphinic acid groups.
TLDR
The novel structural prototype and facile synthesis along with selective and potent Fe(III) binding strongly suggest that pseudo-peptides containing the two or more phosphinic groups as amide-bond surrogates deserve further exploration in medicinal chemistry. Expand
Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase II: Structural Characterization and Biological Activity.
TLDR
Crystal structures of GCPII/hydroxamate complexes revealed an unprecedented binding mode in which the putative P1' glutarate occupies the spacious entrance funnel rather than the conserved glutamate-binding S1' pocket, providing a mechanistic explanation for the structure-activity relationship data. Expand
Biochemical characterization of human glutamate carboxypeptidase III
TLDR
This work reports the cloning, expression, and characterization of recombinant human GCPIII, a GCPII homolog with 67% amino acid identity that has lower N‐acetyl‐l‐aspartyl‐glutamate‐hydrolyzing activity, different pH and salt concentration dependence, and distinct substrate specificity, indicating that these homologs might play different biological roles. Expand
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer
TLDR
Three‐dimensional structures presented here reveal an induced‐fit substrate‐binding mode of this key enzyme and provide essential information for the design of GCPII inhibitors useful in the treatment of neuronal diseases and prostate cancer. Expand
Cerium-Catalyzed α-Hydroxylation Reactions of α-Cyclopropyl β-Dicarbonyl Compounds with Molecular Oxygen
Three α-cyclopropyl β-dicarbonyl compounds have been used as probes for α-radicals as electrophilic reaction intermediates in a cerium-catalyzed α-hydroxylation reaction with molecular oxygen. SinceExpand
Characterization of Glutamate Carboxypeptidase II, its Close Homologs and their Interaction with Ligands
Cancer, group of diseases characterized by an uncon trolled cell growth, represents one of the great challenges of modern clinical research. C urrently, the standard treatment of the cancer diseaseExpand
...
1
2
...